33 results
8-K
EX-3.2
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
and direction of the business and affairs of the Corporation, shall be responsible for corporate policy and strategy, and shall report directly to the Board
CORRESP
THRX
Theseus Pharmaceuticals Inc
7 Feb 24
Correspondence with SEC
12:00am
merger transaction in early November 2023, please specify the “changes in market conditions” that led to this change in strategy.
Response: The Company
UPLOAD
THRX
Theseus Pharmaceuticals Inc
2 Feb 24
Letter from SEC
12:00am
to
this change in strategy.
2. We reissue prior
comment 6 in our letter dated January 22, 2024. Please
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
by terminology such as “believe,” “may,” “will,” “should,” “predict,” “goal,” “strategy,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
and uncertainties on the Company’s standalone strategy and the trading price of the Shares;
Best Offer. The Theseus Board’s belief that (i) as a result
8-K
EX-99.1
zmur51298u165dg1lhdl
25 May 23
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST
5:04pm
8-K
EX-99.2
fxl81r3euokb8
25 May 23
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST
5:04pm
8-K
EX-99.1
xlweqn8
11 May 23
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results
7:09am
S-3
llx0 q8lml
3 Nov 22
Shelf registration
9:06am
8-K
EX-99.1
h9cc4afu n6
3 Nov 22
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third
7:00am
8-K
EX-99.1
u2ln0t
19 Oct 22
Theseus Pharmaceuticals Appoints Steven Stein, M.D. to Board of Directors
7:15am
8-K
EX-99.1
1i2yrp
11 Aug 22
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Second
7:15am
8-K
EX-99.1
r3f4gqzrhi0chjc
18 May 22
Theseus Pharmaceuticals Appoints Donald Hayden to Board of Directors
4:22pm
8-K
EX-99.1
43axf0
12 May 22
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2022 Financial Results
7:15am